CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($) $ in Millions	Total	Total Crown Equity	Common Stock	Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2021	$ 2,330	$ 1,912	$ 630	$ 0	$ 3,180	$ (1,898)	$ 418
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	246	216			216		30
Other comprehensive income (loss)	62	59				59	3
Dividends declared	(38)	(27)			(27)		(11)
Restricted stock awarded	0	0	1		(1)
Stock-based compensation	10	10			10
Common stock repurchased	(350)	(350)	(15)		(335)
Balance at end of period at Mar. 31, 2022	2,260	1,820	616	0	3,043	(1,839)	440
Balance at beginning of period at Dec. 31, 2021	2,330	1,912	630	0	3,180	(1,898)	418
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	733
Other comprehensive income (loss)	(116)					(106)
Balance at end of period at Sep. 30, 2022	2,135	1,666	600	0	3,070	(2,004)	469
Balance at beginning of period at Mar. 31, 2022	2,260	1,820	616	0	3,043	(1,839)	440
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	329	295			295		34
Other comprehensive income (loss)	(117)	(107)				(107)	(10)
Dividends declared	(39)	(26)			(26)		(13)
Restricted stock awarded	0	0	1		(1)
Stock-based compensation	6	6			6
Common stock issued	1	1			1
Common stock repurchased	(250)	(250)	(11)		(239)
Balance at end of period at Jun. 30, 2022	2,190	1,739	606	0	3,079	(1,946)	451
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	158	127			127		31
Other comprehensive income (loss)	(61)	(58)				(58)	(3)
Dividends declared	(37)	(27)			(27)		(10)
Stock-based compensation	7	7			7
Common stock repurchased	(122)	(122)	(6)		(116)
Balance at end of period at Sep. 30, 2022	2,135	1,666	600	0	3,070	(2,004)	469
Balance at beginning of period at Dec. 31, 2022	2,287	1,849	600	0	3,141	(1,892)	438
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	122	102			102		20
Other comprehensive income (loss)	104	103				103	1
Dividends declared	(36)	(29)			(29)		(7)
Restricted stock awarded	0	0	1	(1)
Stock-based compensation	11	11		11
Common stock repurchased	(6)	(6)		(6)
Balance at end of period at Mar. 31, 2023	2,482	2,030	601	4	3,214	(1,789)	452
Balance at beginning of period at Dec. 31, 2022	2,287	1,849	600	0	3,141	(1,892)	438
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	509
Other comprehensive income (loss)	142					144
Balance at end of period at Sep. 30, 2023	2,828	2,341	604	12	3,473	(1,748)	487
Balance at beginning of period at Mar. 31, 2023	2,482	2,030	601	4	3,214	(1,789)	452
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	187	157			157		30
Other comprehensive income (loss)	73	75				75	(2)
Dividends declared	(28)	(28)			(28)
Stock-based compensation	6	6		6
Common stock repurchased	(5)	(5)		(5)
Balance at end of period at Jun. 30, 2023	2,715	2,235	601	5	3,343	(1,714)	480
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	200	159			159		41
Other comprehensive income (loss)	(35)	(34)				(34)	(1)
Dividends declared	(62)	(29)			(29)		(33)
Restricted stock awarded	0	0	3	(3)
Stock-based compensation	10	10		10
Common stock issued	1	1		1
Common stock repurchased	(1)	(1)		(1)
Balance at end of period at Sep. 30, 2023	$ 2,828	$ 2,341	$ 604	$ 12	$ 3,473	$ (1,748)	$ 487